# Shenzhen Hepalink Pharmaceutical Group Co., Ltd. – FDA Inspection, Jun 13, 2025

Source: https://www.keypedia.com/records/fda_inspections/shenzhen-hepalink-pharmaceutical-group-co-ltd/4479056b-15e3-42ef-845a-18902e510bfa
Source feed: FDA_Inspections

> FDA inspection 1276175 of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., June 13, 2025. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276175
- Company Name: Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Inspection Date: 2025-06-13
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Officers

- [Tonia F. Bernard](https://www.keypedia.com/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)

Company: https://www.keypedia.com/companies/shenzhen-hepalink-pharmaceutical-group-co-ltd/b23022d9-a3c3-493b-87c3-9c00c755fdbf

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8